AT363468T

Ningalin b analogs employable for reversing multidrug resistance

Abstract

(-- 57) summary -- drug resistance (MDR) is conquered using the analog of ニンガリン B lacking in peculiar cell obstacle activity, and the transformed cell containing a human colorectal cancer cell line (HCT116/VM46) is again made into susceptibility, for example about various cell obstacle agents, such as vinblastine and doxorubicin. Re-susceptibility-ization is attained by a low dose rather than ベラパミル which is an archetypal medicine. . The total synthesis of ニンガリンB and its analog is based on the heterocyclic アザジン Diels Alder strategy (1, 2, 4, 5-tetra-gin ->1, 2-Giadinh -> pyrrole) in which it was suitable ideal for construction of the pyrrole nucleus which is found out by the product of nature and to which the functional group was given with high density. It is attained using brief and efficient approach.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

11 members in 8 offices

This recordMember, by publication datePriority claim

Priority claims1

Priority claims
DocumentOfficeKindDate
18610600United States of AmericaP

Members11

Family members, oldest first
DocumentOfficeKind
CA2401673A1CanadaA1
WO0164635A1World Intellectual Property Organization (WIPO)A1
AU4195201AAustraliaA
EP1263723A1European Patent Office (EPO)A1
JP2003525271AJapanA
US2003220320A1United States of AmericaA1
EP1263723A4European Patent Office (EPO)A4
EP1263723B1European Patent Office (EPO)B1
AT363468TThis recordAustriaT
DE60128661D1GermanyD1
US7250409B2United States of AmericaB2